IPEM Topical Report: A 2018 IPEM survey of MRI use for external beam radiotherapy treatment planning in the UK

Abstract

Introduction/Background: The benefits of integrating MRI into the radiotherapy pathway are well published, however there is little consensus in guidance on how to commission or implement its use. With a view to developing consensus guidelines for the use of MRI in external beam radiotherapy (EBRT) treatment planning in the UK, a survey was undertaken by an Institute of Physics and Engineering in Medicine (IPEM) working-party to assess the current landscape of MRI use in EBRT in the UK. Methods: A multidisciplinary working-party developed a survey to understand current practice using MRI for EBRT treatment planning; investigate how MRI is currently used and managed; and identify knowledge gaps. The survey was distributed electronically to radiotherapy service managers and physics leads in 71 UK radiotherapy (RT) departments (all NHS and private groups). Results: The survey response rate was 87% overall, with 89% of NHS and 75% of private centres responding. All responding centres include EBRT in some RT pathways: 94% using Picture Archiving and Communication System (PACs) images potentially acquired without any input from RT departments, and 69% had some form of MRI access for planning EBRT. Most centres reporting direct access use a radiology scanner within the same hospital in dedicated (26%) or non-dedicated (52%) RT scanning sessions. Only two centres reported having dedicated RT MRI scanners in the UK, lower than reported in other countries. Six percent of radiotherapy patients in England (data not publically available outside of England) have MRI as part of their treatment, which again is lower than reported elsewhere. Although a substantial number of centres acquire MRI scans for treatment planning purposes, most centres acquire less than five patient scans per month for each treatment site. Commissioning and quality assurance of both image registration and MRI scanners was found to be variable across the UK. In addition, staffing models and training given to different staff groups varied considerably across the UK, reflecting the current lack of national guidelines. Conclusion: The primary barriers reported to MRI implementation in EBRT planning included costs (e.g., lack of a national tariff for planning MRI), lack of MRI access and/or capacity within hospitals. Despite these challenges, significant interest remains in increasing MRI-assisted EBRT planning over the next five years.

Does an immobilization mask have added value during planning magnetic resonance imaging for stereotactic radiotherapy of brain tumours?

“…The validation of image registration is impeded by the lack of a “gold standard” criterion for registration accuracy tests, as discussed by Speight et al [20] . As a consequence, the validation process is highly user-dependent and relies on the skills of the user.…”

Implementation of Stereotactic MRI-Guided Adaptive Radiotherapy (SMART) for Hepatobiliary and Pancreatic Cancers in the United Kingdom – Fifty in Five

“…The ViewRay MRIdian® combines a 0.35T split superconducting magnet with a 6 MV linear accelerator [16]. This results in a linac with significantly different characteristics from a conventional linac, as summarised in There is currently a lack of MRI expertise within the radiotherapy physics community, for example, only a small number of centres have experience with dedicated MR-sims [17]. Engagement with experts in this field is key in terms of commissioning and MR safety training.…”

Magnetic Resonance Imaging Simulation for Anal and Rectal Cancer – Optimising the Patient Experience

“…Its prevalence around the world is varied and dependent on the availability of dedicated MRI simulation equipment [3]. Within the UK, only 6% of radiotherapy patient treatments used MRI guidance in 2018 and only two radiotherapy centres had dedicated radiotherapy MRI equipment [4]. However, the rationale for the increased use of MRI simulation in radiotherapy is building, through increased evidence of the benefit to patients [5e8], the development of new techniques, such as MRI-only planning [9e11], and recommendations from national bodies on commissioning and use [12,13].…”